{"title": "Protein content as a marker for response to therapy in brain cancer", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/medical_imaging.xml", "value": "Protein content as a marker for response to therapy in brain cancer"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/02/190228113537.htm"}], "link": "https://www.sciencedaily.com/releases/2019/02/190228113537.htm", "summary": "Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein content of tumors correlates with response to treatment and survival.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/medical_imaging.xml", "value": "Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein content of tumors correlates with response to treatment and survival."}, "published": "Thu, 28 Feb 2019 11:35:37 EST", "published_parsed": [2019, 2, 28, 16, 35, 37, 3, 59, 0], "id": "https://www.sciencedaily.com/releases/2019/02/190228113537.htm", "guidislink": false}